Skip to content

Multivitamin trial in preeclampsia reports lower urine protein

Adding a multivitamin to magnesium sulfate lowered urine protein and some reported complications; blood pressure differences between groups were not statistically significant.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

Among pregnant women with preeclampsia, the multivitamin group had lower urine protein and fewer reported cases of bleeding after birth, low birth weight and newborn intensive care admission than the magnesium-only group. Blood pressure showed no statistically significant difference between groups. These results concern the clinical treatment setting studied.

Keep in mind

The abstract does not report blinding, multivitamin ingredient amounts or how long maternal and newborn outcomes were tracked. This abstract-based summary cannot establish which ingredient contributed to the differences.

THE NUMBERS, WITH CONTEXT

What researchers found

With multivitamin: 0.71 ± 0.31 g; magnesium alone: 0.92 ± 0.28 g

Protein in urine collected over 24 hours

After 2 weeks, multivitamin plus magnesium sulfate versus magnesium sulfate alone (P < 0.001). The abstract does not define ±.

J Health Popul Nutr, 2025 · Original source ↓

Measurements and complications

The trial examined urine protein, placental blood flow and clotting tests alongside maternal and newborn complications. Laboratory and ultrasound findings describe different outcomes from complications experienced by mothers or babies.

Uncertain eclampsia result

Only the magnesium-only group had cases of eclampsia, but the comparison was not statistically significant. That leaves the treatment's effect on this outcome uncertain; it does not demonstrate prevention.

CHECK THE ORIGINAL

The original publication

Effects of multivitamin combined with magnesium sulfate versus magnesium sulfate alone on hemodynamics, coagulation, and maternal-infant outcomes in preeclampsia: a randomized controlled study.

Gao S, Ming J, Sun F et al.
J Health Popul Nutr · 2025

PubMed ID
41476304
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.